Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial

J.P. Mohr(The Ohio State University), Alan J. Moskowitz(Icahn School of Medicine at Mount Sinai), Andreas Hartmann(Novartis (Switzerland)), Rustam Al‐Shahi Salman(University of Edinburgh), Jessica Overbey(Berry & Associates (United States)), Catharina J.M. Klijn(University Medical Center Utrecht), Claudia S. Moy(National Institute of Neurological Disorders and Stroke), Xavier Barreau(Centre Hospitalier Universitaire de Bordeaux), Michael K. Parides(Icahn School of Medicine at Mount Sinai), Charlotte Cordonnier(Inserm), Rüdiger von Kummer(Los Angeles Medical Center), Christian Stapf(University of Leicester), Ellen Moquete(Icahn School of Medicine at Mount Sinai), Éric Vicaut(Université Paris Cité), Richard Libman(Long Island Jewish Medical Center), Marco Antônio Stefani(Universidade Federal do Rio Grande do Sul), William L. Young(University of California, San Francisco), Kirsty Harkness(Royal Hallamshire Hospital), Alessandra Biondi, Emmanuel Houdart(Hôpital Lariboisière), Joachim Berkefeld(Klinik und Poliklinik für Neurologie)
The Lancet
November 21, 2013
Cited by 1,181


Related Papers